Univ. Prof. Dr. med. G√ľnther Gastl

list of publications

Treg(s) in Cancer: Friends or Foe?

Wolf D, Sopper S, Pircher A, Gastl G, Wolf AM

J Cell Physiol 1 Nov 2015; 230(11)2598-605.

Drug Transporter-Mediated Protection of Cancer Stem Cells From Ionophore Antibiotics

Boesch M, Zeimet AG, Rumpold H, Gastl G, Sopper S, Wolf D

Stem Cells Transl Med 1 Sep 2015; 4(9)1028-32.

Loss of membranous expression of the intracellular domain of EpCAM is a frequent event and predicts poor survival in patients with pancreatic cancer

Fong D, Moser P, Kasal A, Seeber A, Gastl G, Martowicz A, Wurm M, Mian C, Obrist P, Mazzoleni G, Spizzo G

Histopathology 1 Oct 2013; epub().

The role of the e3 ligase cbl-B in murine dendritic cells

Wallner S, Lutz-Nicoladoni C, Tripp CH, Gastl G, Baier G, Penninger JM, Stoitzner P, Wolf D

PLoS One 1 Jun 2013; 8(6).

EpCAM overexpression prolongs proliferative capacity of primary human breast epithelial cells and supports hyperplastic growth

Martowicz A, Rainer J, Lelong J, Spizzo G, Gastl G, Untergasser G.

Mol Cancer. 1 Jun 2013; 12()56.

Phenotype-dependent effects of EpCAM expression on growth and invasion of human breast cancer cell lines.

Martowicz A, Spizzo G, Gastl G, Untergasser G.

BMC Cancer. 1 Oct 2012; 12()501.

Reinforcement of Cancer Immunotherapy by Adoptive Transfer of Cbl-b Deficient CTL combined with Dendritic Cell Vaccination

Lutz-Nicoladoni C, Wallner S, Stoizner P, Pircher M, Gruber T, Wolf AM, Gastl G, Penninger J, Baier G, Wolf D

Immunol & Cell Biol 1 Jan 2012; 90(1)130-4.

EpCAM expression in primary tumour tissues and metastases: an immunohistochemical analysis.

Spizzo G, Fong D, Wurm M, Ensinger C, Obrist P, Hofer C, Mazzoleni G, Gastl G, Went P.

J Clin Pathol. 1 May 2011; 64(5)415-20.

Current treatment concepts of Philadelphia-negative MPN

Wolf D, Rudzki J, Gastl G.

Curr Cancer Drug Targets 1 Jan 2011; 11(1)44-55.

Effects of EpCAM overexpression on human breast cancer cell lines

Gostner JM, Fong D, Wrulich OA, Lehne F, Zitt M, Hermann M, Krobitsch S, Martowicz A, Gastl G, Spizzo G

BMC Cancer 1 Jan 2011; 11()45.

Possible role for gene expression profiling in predicting responses to conventional or targeted drugs in patients with chronic myeloid leukemia.

Schmidt S, Gastl G, Wolf D.

Leuk Lymphoma 1 Apr 2008; 49(4)643-7.

TROP2: a novel prognostic marker in squamous cell carcinoma of the oral cavity.

Fong D, Spizzo G, Gostner JM, Gastl G, Moser P, Krammel C, Gerhard S, Rasse M, Laimer K.

Mod Pathol. 1 Feb 2008; 21(2)186-91.

EpCAM expression in squamous cell carcinoma of the oral cavity: frequency and relationship to clinicopathologic features.

Laimer K, Fong D, Gastl G, Obrist P, Kloss F, Tuli T, Gassner R, Rasse M, Norer B, Spizzo G.

Oral Oncol 1 Jan 2008; 44(1)72-7.

Methylation status of the Ep-CAM promoter region in human breast cancer cell lines and breast cancer tissue.

Spizzo G, Gastl G, Obrist P, Fong D, Haun M, Grunewald K, Parson W, Eichmann C, Millinger S, Fiegl H, Margreiter R, Amberger A.

Cancer Lett. 8 Feb 2007; 246(1-2)253-61. Epub 2006 Apr 18.

High EGFR expression predicts poor prognosis in patients with squamous cell carcinoma of the oral cavity and oropharynx: a TMA-based immunohistochemical analysis.

Laimer K, Spizzo G, Gastl G, Obrist P, Brunhuber T, Fong D, Barbieri V, Jank S, Doppler W, Rasse M, Norer B.

Oral Oncol. 1 Feb 2007; 43(2)193-8. Epub 2006 Jul 18.

Overexpression of epithelial cell adhesion molecule (Ep-CAM) is an independent prognostic marker for reduced survival of patients with epithelial ovarian cancer.

Spizzo G, Went P, Dirnhofer S, Obrist P, Moch H, Baeuerle PA, Mueller-Holzner E, Marth C, Gastl G, Zeimet AG.

Gynecol Oncol. 1 Nov 2006; 103(2)483-8. Epub 2006 May 6.